Gilead Sciences (GILD) reported its Q2 2026 results on August 4, 2026, after market close. The company reported revenue of 7803 million USD. The reported earnings per share (EPS) was -6.75 USD, beating the analyst estimate of -7.26 USD by 7.0%. Following the release, the stock price reacted with a move of -2.58%.
Generated automatically from our data — as of August 13, 2026
Key figures at a glance
Estimate (EPS): -7.26 USD
Reported (EPS): -6.75 USD
Price reaction: -2.6%
Frequently asked questions
Did Gilead Sciences beat or miss earnings-per-share expectations?
Gilead Sciences beat the analyst estimate of -7.26 USD earnings per share (Q2 2026) by 7%, reporting -6.75 USD.
How did Gilead Sciences stock react to the earnings report?
Gilead Sciences stock fell 2.6% on the trading day following the release.
What was Gilead Sciences's revenue in Q2 2026?
Gilead Sciences reported revenue of 7,803M USD in Q2 2026.